Dr. Reggie Gaudino oversees all scientific research and development for Front Range Biosciences, and together the team at Front Range Biosciences applies the research to the development of new and improved Cannabis cultivars. Dr. Gaudino was formerly with Steep Hill, Inc where he oversaw all scientific research and development and was responsible for building the cannabis genetics and research division at Steep Hill. Dr. Gaudino directed the research team at Steep Hill which led to the development of GenKit™, the first commercially offered cannabis DNA-based sex test, and subsequently the first commercially offered Cannabis DNA-based CBD test. The research from Dr. Gaudino and his team has been peer-reviewed and published, leading to important new discoveries in the cannabis industry. He is internationally recognized as a leader in the field of cannabis genetics where his former experience as a Patent Agent with Sequenom brings valuable insight to the cannabis industry.